Drugs / GW-2000-02
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00675948 | Apr 2002 → Sep 2006 | cancer | Jazz Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00674609 | Feb 2002 → Feb 2004 | cancer | Jazz Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT01606189 | Dec 2001 → Sep 2002 | — | Jazz Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GW-2000-02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01606189 ↗ |
| Known as | THC Alone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00674609 ↗ |
| Route | Other | “Subjects received study medication delivered in 100 µl actuations by a pump action oromucosal spray.” NCT00675948 ↗ |